Home / Posts Tagged "FDA for emergency"

The U.S. Food and Drug Administration has declined Humanigen Inc's (HGEN.O) request for emergency use authorization (EUA) of its lenzilumab drug to treat newly hospitalized COVID-19 patients, as stated by the company on Thursday. "In its letter, FDA stated that it was unable to conclude that the known